AI-generated summary
The authors developed paclitaxel-loaded nanoparticles containing gold nanorods and perfluorohexane, targeted to folate-receptor-overexpressing tumor cells. Pulsed laser irradiation was reported to vaporize the perfluorohexane, rupturing the particles and releasing the drug, which induced cancer cell apoptosis in cell and in vivo experiments. The authors report efficient tumor suppression in vivo, but the abstract does not give sample sizes or controls.
- Who or what was studied
- Tumor-bearing cells and animals (folate receptor-overexpressing cancer models); human participants not described
- Limits stated in the abstract
- The abstract does not report animal numbers, control groups or statistical details, and the work appears to be preclinical cell and animal research.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.